Trial

NCT02851381

Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic Cancer
UnknownWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Condition
Pancreatic Cancer
Intervention
FG-3019
Why stopped
The patient passed before treatment could be started
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-10-07